Literature DB >> 29724376

Reply to Tsivgoulis and colleagues comments.

Douglas S Goodin1, Dimos D Mitsikostas2.   

Abstract

Year:  2018        PMID： 29724376     DOI： 10.1016/j.msard.2018.03.011

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN： 2211-0348            Impact factor:   4.339


× No keyword cloud information.
  1 in total

1.  Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis.

Authors:  Dimitrios Papadopoulos; Dimos-Dimitrios D Mitsikostas
Journal:  CNS Drugs       Date:  2018-11       Impact factor: 5.749
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.